ASD MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ASD MEDICAL
Largest movements
- Cash +€54,699
up €54,699 (+161%), from €34,056 to €88,756
mainly Net result for the year (+€44,038) and Tax, wage and social debts (+€6,860)
- Tangible fixed assets -€5,088
down €5,088 (-41.5%), from €12,246 to €7,158
- Receivables within one year -€1,656
down €1,656 (-59.2%), from €2,797 to €1,140
- Reserves +€44,038
up €44,038 (+102%), from €43,360 to €87,398
- Tax, wage and social debts +€6,860
up €6,860 (+427%), from €1,605 to €8,464
- Other debts -€4,449
down €4,449 (-70.6%), from €6,301 to €1,852
- Gross operating margin +€37,884
up €37,884 (+131%), from €28,874 to €66,758
- Taxes +€10,406
up €10,406 (+147%), from €7,058 to €17,464
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €52,266 | €99,404 | +€47,138 | +90.2% |
| Fixed assets | 21/28 | €14,596 | €9,508 | -€5,088 | -34.9% |
| Tangible fixed assets | 22/27 | €12,246 | €7,158 | -€5,088 | -41.5% |
| Furniture and vehicles | 24 | €12,246 | €7,158 | -€5,088 | -41.5% |
| Financial fixed assets | 28 | €2,350 | €2,350 | = | 0.0% |
| Current assets | 29/58 | €37,670 | €89,896 | +€52,226 | +139% |
| Amounts receivable within one year | 40/41 | €2,797 | €1,140 | -€1,656 | -59.2% |
| Other amounts receivable | 41 | €2,797 | €1,140 | -€1,656 | -59.2% |
| Cash at bank and in hand | 54/58 | €34,056 | €88,756 | +€54,699 | +161% |
| Deferred charges and accrued income | 490/1 | €817 | - | -€817 | |
| Total equity and liabilities | 10/49 | €52,266 | €99,404 | +€47,138 | +90.2% |
| Equity | 10/15 | €44,360 | €88,398 | +€44,038 | +99.3% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €43,360 | €87,398 | +€44,038 | +102% |
| Distributable reserves | 133 | €43,360 | €87,398 | +€44,038 | +102% |
| Amounts payable | 17/49 | €7,906 | €11,005 | +€3,100 | +39.2% |
| Amounts payable within one year | 42/48 | €7,906 | €11,005 | +€3,100 | +39.2% |
| Trade debts | 44 | - | €689 | +€689 | |
| Suppliers | 440/4 | - | €689 | +€689 | |
| Taxes, remuneration and social security | 45 | €1,605 | €8,464 | +€6,860 | +427% |
| Taxes | 450/3 | €1,605 | €8,464 | +€6,860 | +427% |
| Other amounts payable | 47/48 | €6,301 | €1,852 | -€4,449 | -70.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,979 | €5,088 | +€109 | +2.2% |
| Other operating charges | 640/8 | €583 | - | -€583 | |
| Gross operating margin | 9900 | €28,874 | €66,758 | +€37,884 | +131% |
| Operating profit (loss) | 9901 | €23,312 | €61,670 | +€38,357 | +165% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €208 | €168 | -€41 | -19.5% |
| Recurring financial charges | 65 | €208 | €168 | -€41 | -19.5% |
| Profit (loss) for the period before taxes | 9903 | €23,104 | €61,502 | +€38,398 | +166% |
| Income taxes | 67/77 | €7,058 | €17,464 | +€10,406 | +147% |
| Profit (loss) for the period | 9904 | €16,047 | €44,038 | +€27,991 | +174% |
| Profit (loss) for the period to be appropriated | 9905 | €16,047 | €44,038 | +€27,991 | +174% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.